Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...